AbbVie Inc. against Bayer Aktiengesellschaft — live side-by-side technical comparison.
Prices as of 2026-10-09T20:01:20+00:00 UTC · updates daily
ABBV leads 4 of the 5 windows we measure — over 1 month ABBV is +10.2% and BAYN.DE -11.1%; over year to date ABBV is +21.0% and BAYN.DE +18.3%.
| ABBV | BAYN.DE | |
|---|---|---|
| Price | $276.47 | $43.77 |
| 1 day | +1.5% | +2.8%lead |
| 5 days | +5.2%lead | -2.6% |
| 1 month | +10.2%lead | -11.1% |
| 6 months | +30.2%lead | +8.2% |
| Year to date | +21.0%lead | +18.3% |
| 52-week position | 99% of range | 64% of range |
| 52-week range | $190.75–$277.60 | $25.78–$53.92 |
| vs 50-day average | above $258.89 | below $48.20 |
| vs 200-day average | above $232.65 | above $43.17 |
| RSI (14) | 73 | 29 |
| Next earnings | 2026-10-30 | 2026-11-03 |
ABBV trades at $276.47, above its 50-day average of $258.89, and above the 200-day at $232.65. It sits at 99% of its 52-week range ($190.75–$277.60); 14-day RSI is 73, in overbought territory; an average session moves it about 2.1%. For levels, the first level overhead is $300.00 (8.5% away) and the first support below is $275.00 (0.5% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
BAYN.DE trades at $43.77, below its 50-day average of $48.20, and above the 200-day at $43.17. It sits at 64% of its 52-week range ($25.78–$53.92); 14-day RSI is 29, in oversold territory; an average session moves it about 3.2%. For levels, the first level overhead is $45.00 (2.8% away) and the first support below is $43.17 (1.4% down). On the checklist the page runs for every asset, 2 of 6 checks read bullish — the lean is bearish.
BAYN.DE is the more volatile of the two — an average session moves it 3.2% against 2.1% for ABBV, so an identical position size carries roughly 1.5× the daily risk.
The comparison turns on those levels: ABBV clearing $300.00 or losing $275.00; BAYN.DE clearing $45.00 or losing $43.17. Until one of them gives way, the relative reading above stands.